MAM
CRL icon

Madison Asset Management’s Charles River Laboratories CRL Stock Holding History

Madison Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8M Buy
16,777
+25
+0.1% +$4.45K 0.05% 201
2026
Q1 		$2.89M Buy
16,752
+1,130
+7% +$210K 0.04% 212
2025
Q4 		$3.12M Buy
15,622
+3,256
+26% +$591K 0.04% 206
2025
Q3 		$1.93M Buy
+12,366
New +$1.96M 0.02% 242

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Madison Asset Management's CRL Position: Q2 2026 in Review

Madison Asset Management increased its Charles River Laboratories (CRL) stake by 0.15% in Q2 2026, buying an estimated $4.45K and bringing the position to 16,777 shares worth $3.8M. The position accounts for 0.05% of the portfolio, ranked #201.

Madison Asset Management first reported a position in CRL in Q3 2025 and has held it in 4 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Madison Asset Management held 16,777 shares of Charles River Laboratories worth $3.8M as of Q2 2026.
  • Madison Asset Management bought 25 Charles River Laboratories shares in Q2 2026, an estimated $4.45K.
  • Charles River Laboratories made up 0.05% of Madison Asset Management's portfolio in Q2 2026, its #201 holding.
  • Madison Asset Management first reported a position in Charles River Laboratories in Q3 2025 and has held it in 4 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Madison Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.